Search Results 501-510 of 7713 for beyondfor
Dr. Ackerman's Sudden Death Genomics Lab leverages the expertise of other scientists on sudden death and cardiac conditions at Mayo Clinic and at other ...
We will draw a simple random sample of OCHC patients (N=1000, age 18+) with 1:1 randomization of communication about COVID-19 and availability of rapid testing ...
Concurrent anti-tumor therapy beyond gemcitabine and nab-paclitaxel; Implantable electronic medical devices in the torso, such as pacemakers; Known severe ...
The primary purpose of this study is to assess the accuracy of the Philips High Precision 3D Ablation Solution software on cross-sectional imaging evaluation of ...
CCaTS Education Resources annually presents the Excellence in Mentorship Award to the Mayo Clinic faculty member making outstanding mentoring contributions.
The purpose of this study is to develop patient-derived organoid cultures of urothelial carcinoma from non-invasively obtained urine samples and to characterize ...
Tinostamustine (EDO-S101) is a new chemical entity, an AK-DAC (a first-in-class alkylating deacetylase inhibiting molecule) that, in preclinical studies, has ...
Response-based treatment may be effective in treating acute myeloid leukemia or myelodysplastic syndrome in younger patients with Down syndrome while reducing ...
The purpose of this study is to identify subtype-specific signatures for breast cancer using genomic positioning of plasma DNA fragments, and to validate ...
About this study. The purpose of this trial is to evaluate the antitumor activity of Pembrolizumab in patients with advanced mycosis fungoides (MF) as ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.